Re-treatment of previous non-responders and relapsers to interferon plus ribavirin with peginterferon alfa-2a (40KD), ribavirin ± amantadine in patients with chronic hepatitis C: randomized multicentre clinical trial

Re-treatment of previous non-responders and relapsers to interferon plus ribavirin with peginterferon alfa-2a (40KD), ribavirin ± amantadine in patients with chronic hepatitis C: randomized multicentre clinical trial

Introduction. A large number of patients with chronic hepatitis C have not been cured with interferon-based therapy. Therefore, we evaluated the efficacy of amantadine combined with the standard of care (pegylated interferon plus ribavirin) in patients who had not responded to or had relapsed after...

Full description

Bibliographic Details
Main Authors: Mario G. Pessôa, Hugo Cheinquer, Paulo R.L. Almeida, Giovanni F. Silva, Maria Patelli J.S. Lima, Raymundo Paraná, Marco A. Lacerda, Edison R. Parise, José R.B. Pernambuco, Suelene S. Pedrosa, Rosângela Teixeira, Hoel Sette, Jr, Fernando Tatsch
Format: Article
Language:English
Published: Elsevier 2012-01-01
Series:Annals of Hepatology
Subjects:
Hepatitis C
Re-treatment
Peginterferon alfa-2a (40KD)
Amantadine
Online Access:http://www.sciencedirect.com/science/article/pii/S1665268119314863

Internet

http://www.sciencedirect.com/science/article/pii/S1665268119314863

Similar Items